- ►bloodjournal.org SJ Horning, NJ Chao, RS Negrin, RT Hoppe … - Blood, 1997 - Am Soc Hematology One hundred nineteen patients with relapsed or refractory Hodgkin's disease (HD)
received high-dose therapy followed by autologous hematopoietic progenitor cell
transplantation. Three preparatory regimens, selected on the basis of prior ... Cited by 200 - Related articles - BL Direct - All 4 versions
- ►jcojournal.org [PDF] FR Appelbaum, KM Sullivan, CD Buckner, RA … - Journal of Clinical Oncology, 1987 - jcojournal.org From the Fred Hutchinson Cancer Research Center, and the Division of Oncology,
University of Washington School ofMedi- cine, Seattle. Submitted October 3,
1986; accepted April 27, 1987. Supported by Public Health Service Grants ... Cited by 177 - Related articles - All 5 versions
- ►bloodjournal.org A Krishnan, S Bhatia, ML Slovak, DA Arber, … - Blood, 2000 - Am Soc Hematology High-dose chemoradiotherapy (HDT) with stem cell rescue has become the treatment
of choice for patients with Hodgkin's disease (HD) and non-Hodgkin's lymphoma
(NHL) who have a suboptimal response to initial therapy or for patients ... Cited by 168 - Related articles - BL Direct - All 6 versions
- ►bloodjournal.org M Andre, M Henry-Amar, D Blaise, P Colombat, … - Blood, 1998 - Am Soc Hematology Autologous stem-cell transplantation has become a widely used therapy in
Hodgkin's disease (HD). To appreciate the early and late risks associated with
this procedure, its lethal toxicity and effects on the incidence of ... Cited by 131 - Related articles - BL Direct - All 5 versions
- ►jcojournal.org [PDF] S Jagannath, JO Armitage, KA Dicke, SL … - Journal of Clinical Oncology, 1989 - jcojournal.org Sixty-one patients with relapsed Hodgkin's disease who had failed a
mechlorethamine, vincristine, procarbazine, and prednisone (MOPP)- and a doxoru-
bicin, bleomycin, vinblastine, and dacarbazine (ABVD)-like regimen were ... Cited by 131 - Related articles - All 6 versions
SR Rousey, S Russler, M Gottlieb, RC Ash - The American journal of medicine, 1991 - Elsevier The subjects of this analysis were 186 consecutive patients undergoing
allogeneic marrow transplantation in an adult bone marrow transplant unit
between July 1, 1985, and September 30, 1990, utilizing consistent disease- ... Cited by 122 - Related articles - All 4 versions
- ►jcojournal.org [PDF] RJ Jones, S Piantadosi, RB Mann, RF … - Journal of Clinical Oncology, 1990 - jcojournal.org •PPROXIMATELY half of the patients who present with advanced-stage Hodgkin's
dis- ease will either progress during initial treatment with combination
chemotherapy or relapse afterward.1-3 A select number of these patients who ... Cited by 118 - Related articles - All 5 versions
- ►hematologylibrary.org [PDF] JG Gribben, DC Linch, CR Singer, AK McMillan … - Blood, 1989 - bloodjournal.hematologylibrary.org . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 109 - Related articles - All 5 versions
- ►ascopubs.org [PDF] C Wheeler, JH Antin, WH Churchill, SE Come, … - Journal of Clinical Oncology, 1990 - jco.ascopubs.org Cyclophosphamide, Carmustine, and Etoposide With Autologous Bone Marrow
Transplantation in Refractory Hodgkin's Disease and Non-Hodgkin's Lymphoma: A
Dose-Finding Study ... By Catherine Wheeler, Joseph H. Antin, W. Hallowell ... Cited by 104 - Related articles - All 6 versions
- ►ascopubs.org [PDF] PJ Stiff, S Dahlberg, SJ Forman, AR McCall, … - Journal of Clinical Oncology, 1998 - jco.ascopubs.org Purpose: To determine the toxicity and prognosis of patients with relapsed and
refractory diffuse aggres- sive non-Hodgkin's lymphoma (NHL) who underwent an
autologous bone marrow transplant (ABMT) using augmented preparative ... Cited by 99 - Related articles - BL Direct - All 7 versions
